Ayurvedic Therapeutic Approach in Gambhira Vatarakta
DOI:
https://doi.org/10.47070/ijapr.v14i10.4492Keywords:
Ayurveda, Gambhira VataraktaAbstract
Gambhira Vatarakta is an advanced stage of Vatarakta characterized by the involvement of deeper tissues, leading to severe pain, discoloration, inflammation, and functional disability. Owing to its chronicity and recurrent nature, the condition remains therapeutically challenging. Ayurveda advocates a multimodal treatment approach incorporating Sodhana and Samana therapies to address the underlying Dosha imbalance and prevent disease progression. A patient presented with dry, scaly itchy lesions along with blackish discolouration and severe pain in the lower limbs, clinically diagnosed as Gambhira Vatarakta. The treatment protocol was formulated based on the principles of Vatarakta Chikitsa described in the classical Ayurvedic texts. Management included appropriate internal Ayurvedic medications along with external and purification therapies, namely Jalaukavacharana, Kshalana, Kashaya Dhara, Snehapana, Abhyanga, Virecana, and Kshira Basti. The patient's clinical response was assessed through serial evaluation of pain, skin discoloration, and disease progression during treatment and follow-up. The patient demonstrated gradual and significant clinical improvement over the treatment period. Pain in the lower limbs reduced substantially, and the scaly lesion and blackish discoloration of the skin improved markedly. No new lesions developed during the course of treatment or subsequent follow-up, indicating sustained remission without recurrence. The patient also reported improvement in functional ability and overall quality of life. This case report highlights the clinical outcome of a patient with Gambhira Vatarakta managed exclusively with Ayurvedic interventions.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 International Journal of Ayurveda and Pharma Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

